JP2023527059A5 - - Google Patents

Info

Publication number
JP2023527059A5
JP2023527059A5 JP2022573217A JP2022573217A JP2023527059A5 JP 2023527059 A5 JP2023527059 A5 JP 2023527059A5 JP 2022573217 A JP2022573217 A JP 2022573217A JP 2022573217 A JP2022573217 A JP 2022573217A JP 2023527059 A5 JP2023527059 A5 JP 2023527059A5
Authority
JP
Japan
Application number
JP2022573217A
Other languages
Japanese (ja)
Other versions
JP2023527059A (ja
JPWO2021240369A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/054546 external-priority patent/WO2021240369A1/en
Publication of JP2023527059A publication Critical patent/JP2023527059A/ja
Publication of JPWO2021240369A5 publication Critical patent/JPWO2021240369A5/ja
Publication of JP2023527059A5 publication Critical patent/JP2023527059A5/ja
Pending legal-status Critical Current

Links

JP2022573217A 2020-05-26 2021-05-25 関節リウマチを治療するためのインターロイキン6受容体に対する抗体を含む組成物およびその使用方法 Pending JP2023527059A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202063030065P 2020-05-26 2020-05-26
US63/030,065 2020-05-26
US202163155125P 2021-03-01 2021-03-01
US63/155,125 2021-03-01
EP21315087.3 2021-05-25
EP21315087 2021-05-25
PCT/IB2021/054546 WO2021240369A1 (en) 2020-05-26 2021-05-25 Compositions comprising an antibody against interleukin-6 receptor for the treatment of rheumatoid arthritis and methods of using same

Publications (3)

Publication Number Publication Date
JP2023527059A JP2023527059A (ja) 2023-06-26
JPWO2021240369A5 JPWO2021240369A5 (https=) 2024-06-03
JP2023527059A5 true JP2023527059A5 (https=) 2024-06-03

Family

ID=76197513

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022573217A Pending JP2023527059A (ja) 2020-05-26 2021-05-25 関節リウマチを治療するためのインターロイキン6受容体に対する抗体を含む組成物およびその使用方法

Country Status (7)

Country Link
US (1) US20230174657A1 (https=)
JP (1) JP2023527059A (https=)
AU (1) AU2021281119A1 (https=)
BR (1) BR112022024020A2 (https=)
CA (1) CA3180369A1 (https=)
IL (1) IL298088A (https=)
WO (1) WO2021240369A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020261431A1 (en) 2019-04-24 2021-12-09 Regeneron Pharmaceuticals, Inc. Methods of diagnosis and treatment of rheumatoid arthritis
EP3980459A1 (en) 2019-06-04 2022-04-13 Sanofi Biotechnology Compositions and methods for treating pain in subj ects with rheumatoid arthritis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215534A (en) 1991-12-02 1993-06-01 Lawrence De Harde Safety syringe system
US6659982B2 (en) 2000-05-08 2003-12-09 Sterling Medivations, Inc. Micro infusion drug delivery device
US6629949B1 (en) 2000-05-08 2003-10-07 Sterling Medivations, Inc. Micro infusion drug delivery device
US8080248B2 (en) * 2006-06-02 2011-12-20 Regeneron Pharmaceuticals, Inc. Method of treating rheumatoid arthritis with an IL-6R antibody
ES2398076T3 (es) 2006-06-02 2013-03-13 Regeneron Pharmaceuticals, Inc. Anticuerpos de alta afinidad contra el receptor de IL-6 humano
JO3417B1 (ar) 2010-01-08 2019-10-20 Regeneron Pharma الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r
US9427531B2 (en) 2010-06-28 2016-08-30 Sanofi-Aventis Deutschland Gmbh Auto-injector
US9248242B2 (en) 2012-04-20 2016-02-02 Safety Syringes, Inc. Anti-needle stick safety device for injection device
US20140155827A1 (en) 2012-12-03 2014-06-05 Mylan, Inc. Medicament information system and method
AU2019329958B2 (en) * 2018-08-29 2025-05-29 Regeneron Pharmaceuticals, Inc. Methods and compositions for treating subjects having rheumatoid arthritis

Similar Documents

Publication Publication Date Title
JP2023527059A5 (https=)
CN305529054S (https=)
CN306298396S (https=)
CN305580314S (https=)
CN305580329S (https=)
CN305668770S (https=)
CN305670904S (https=)
CN305707421S (https=)
CN305723566S (https=)
CN305724072S (https=)
CN305724701S (https=)
CN305749303S (https=)
CN305793313S (https=)
CN305794455S (https=)
CN305797222S (https=)
CN305798241S (https=)
CN305798593S (https=)
CN305799080S (https=)
CN305804390S (https=)
CN305829074S (https=)
CN305829769S (https=)
CN306142821S (https=)
CN306183333S (https=)
CN306193571S (https=)
CN306194597S (https=)